Methylene Blue: Benefits, Evidence, and Safety in 2026

Methylene blue (methylthioninium chloride) is an FDA-approved prescription drug whose only well-established human benefit is treating methemoglobinemia, a blood disorder that stops red cells from releasing oxygen. Arsenic is a grade question: pharmaceutical and USP grade methylene blue is purified and tested against heavy metal limits, while aquarium, textile, and lab reagent grades are not made for people and can contain arsenic, lead, and mercury. The popular cognitive, mood, and longevity claims rest mostly on mechanism and animal data, with thin human evidence, and a 2016 phase 3 Alzheimer's trial of a related compound found no benefit. Methylene blue is also a potent MAO inhibitor, so it carries a real serotonin syndrome risk.

What is methylene blue?

Methylene blue (methylthioninium chloride, often shortened to MB, sold in German-speaking countries as Methylenblau, and catalogued as the dye Basic Blue 9) is a synthetic dye first made in 1876. It became one of the earliest true pharmaceuticals, used against malaria in the late 1800s, and it is still on the market today as a prescription drug. It is a small molecule that donates and accepts electrons easily, which is why it acts as both a dye and a redox agent in the body [1].

In modern medicine its headline role is treating methemoglobinemia, a condition where hemoglobin cannot release oxygen to tissues. Given intravenously, methylene blue rapidly converts the abnormal methemoglobin back to normal hemoglobin. This use is FDA-approved and backed by decades of clinical practice [1].

Emergency physicians, medical toxicologists, anesthesiologists, and critical care teams are the clinicians who use it most. In the consumer market it shows up in a different form: low-dose oral drops, capsules, and IV drips offered at wellness and IV therapy clinics, often next to NAD+ infusions and red light sessions.

How does methylene blue work in the body?

The interesting biology sits inside your mitochondria. Methylene blue can act as an alternative electron carrier in the electron transport chain, effectively bypassing damaged sections and helping cells keep producing ATP. In laboratory and animal work it supports cytochrome c oxidase activity, lowers oxidative stress at low concentrations, and shows neuroprotective effects, according to Rojas, Bruchey and Gonzalez-Lima at the University of Texas at Austin (2012) [2].

This is the mechanistic hook behind every longevity and brain-fog claim you will read online. The logic runs: better mitochondrial function equals more energy, sharper cognition, and slower aging. The logic is reasonable. The problem is that a plausible mechanism in a rat brain slice is not the same as a measured benefit in a healthy human, and methylene blue has a well-known hormetic curve. Low doses may help while higher doses flip to pro-oxidant and can impair the same processes [2].

The same redox chemistry explains its two other actions. Methylene blue inhibits monoamine oxidase A, which raises serotonin and drives the interaction risk covered in the safety section [7]. It also absorbs red light strongly, which is why dentists and dermatologists can activate it with a specific wavelength in photodynamic therapy [6]. That light connection is a separate thing from consumer red light therapy, which uses no dye.

Does methylene blue improve brain fog, memory, and mood?

Here the honest answer is: maybe a little, in specific settings, and the human evidence is early. A 2016 randomized, placebo-controlled functional MRI study by Rodriguez, Duong and colleagues at UT Health San Antonio enrolled 26 healthy adults. A single low oral dose (roughly 280 mg) increased brain activity in regions tied to short-term memory and attention, and was associated with a 7% increase in correct responses during memory retrieval [3]. A separate 2017 study from the University of Texas at Austin explored methylene blue in fear extinction and memory reconsolidation in rats, with effects that depended heavily on the animals' learning profile rather than a clean across-the-board boost [4].

That is close to the entire high-quality human dataset for cognition in healthy people. There are no large, long-term randomized trials showing that daily low-dose methylene blue prevents cognitive decline, lifts depression durably, or extends healthspan in people. The mood claims are especially thin, and they collide directly with the drug’s MAO-inhibiting activity, which is a safety liability rather than a clean antidepressant effect. Treat the brain-fog marketing as a hypothesis, not an established result. If persistent brain fog is your main concern, evidence-guided supplements for brain fog and a workup for the underlying cause are a more grounded starting point.

What did the Alzheimer's trials of methylene blue find?

The largest human test of the methylene blue molecule for the brain was negative. Gauthier and colleagues ran a 15-month phase 3 trial of LMTM (leuco-methylthioninium, also called hydromethylthionine), a stabilized reduced form of methylene blue, in 891 people with mild to moderate Alzheimer's disease across 16 countries. At 75 mg and 125 mg twice daily, the prespecified primary analysis showed no treatment benefit on cognition or daily function compared with a 4 mg control dose, according to the results published in The Lancet (2016) [9].

Can methylene blue help long COVID or chronic fatigue brain fog?

No controlled trial has shown that methylene blue clears the brain fog of long COVID or chronic fatigue syndrome. Clinics that offer it for these conditions are extrapolating from the mitochondrial mechanism. For a broader look at causes and what has been tested, see the guide to long COVID brain fog.

What is methylene blue actually approved and used for?

The gap between what methylene blue is approved to do and what it is sold to do is wide. This table separates the two.

Ifosfamide encephalopathy is a confusion syndrome caused by the chemotherapy drug ifosfamide, and oncology teams give methylene blue for it off label. Critical care teams also use it off label for vasoplegia, a dangerous loss of blood vessel tone after cardiac surgery or in septic shock, where its role is still being studied. Both are hospital uses under close monitoring, not home protocols.

Is methylene blue evidence-based?

Methylene blue is evidence-based for one use and experimental for the rest. Treating acquired methemoglobinemia is FDA-approved and supported by decades of clinical practice [1]. The wellness uses are not: the cognition signal comes from one 26-person single-dose imaging study [3], the mood claims have no durable trial support, and the largest brain trial of a methylene blue derivative was negative [9]. Readers asking in German whether Methylenblau is evidenzbasiert get the same answer: yes for methemoglobinemia, no for brain fog, mood, and longevity.

Evidence grades on this page follow a simple scale. Established means regulatory approval or long standard practice. Promising means controlled studies in a specific clinical niche. Early means small human studies with short follow-up. Insufficient means mechanism, animal work, or anecdote only.

What about antimicrobial, antimalarial, and photodynamic uses?

Methylene blue has real antimicrobial credentials. It was one of the first antimalarial drugs, and modern research continues to study it in combination regimens, including work on blocking malaria transmission by acting on the parasite’s gametocyte stage. Chaumeau and colleagues (2024) tested artesunate, chloroquine, and methylene blue against Plasmodium vivax gametocytes in this setting [5]. In dentistry and dermatology, methylene blue is used in antimicrobial photodynamic therapy, where the dye is applied and then activated by a specific wavelength of light to kill bacteria. Clinical reviews, including Boltes Cecatto and colleagues (2020), describe it as a useful adjunct in periodontal and other localized infections, though not a standalone treatment [6]. These are legitimate, evidence-supported niches, and they are very different from swallowing drops for general wellness.

Methylene blue dosing: what circulates online, and why grade matters

Online protocols usually suggest low oral doses in the range of 0.5 to 4 mg per kilogram of body weight, often 1 to 2 mg/kg, taken once daily or a few times per week. Some sources push much higher. Two cautions apply. First, the human cognitive signal that exists came from controlled single doses, not open-ended daily self-dosing, so extrapolating to a lifelong regimen is guesswork. Second, and more urgent, is product quality.

Only USP or pharmaceutical grade methylene blue is intended for human consumption. Aquarium grade, textile grade, and laboratory reagent grade are not purified to human standards and can contain heavy metals such as arsenic, lead, and mercury, plus other contaminants. The blue color looks identical. The contaminant profile is not. If someone is going to use methylene blue at all, pharmaceutical grade from a verified source is the only defensible choice, ideally under clinician supervision.

How do the doses in the studies compare?

The doses below are the ones stated in the sources this page cites. They are reference points for reading the research, not a protocol.

Does methylene blue contain arsenic?

Pure methylene blue does not contain arsenic. The molecule is built from carbon, hydrogen, nitrogen, sulfur, and chlorine. Arsenic enters as a contaminant from manufacturing, and the risk depends on the grade. Pharmaceutical and USP grade product is purified and tested against pharmacopeial limits for heavy metals, including arsenic, before it is sold for human use.

Aquarium, textile, and laboratory reagent grades are made to dye fabric, stain slides, or treat fish tanks. They are not held to those limits and can carry arsenic, lead, mercury, and other impurities. Someone who swallows them daily for brain fog is taking an unregulated chemical, and any heavy metal load adds up over time.

How can you check a methylene blue product for heavy metals?

1. Look for USP or pharmaceutical grade on the label, not "high purity" or "lab grade".
2. Ask the seller for a lot-specific certificate of analysis that reports heavy metals, including arsenic, lead, mercury, and cadmium.
3. Prefer product dispensed by a licensed pharmacy on a prescription, where the drug supply chain is regulated by the FDA and state boards of pharmacy.
4. Treat any product sold for aquariums or labs as unsuitable for people, whatever its color or price.

If heavy metal exposure is already a worry, a clinician can order testing. The guide to heavy metal testing explains what blood and urine tests can and cannot show.

Is methylene blue safe? The serotonin syndrome and G6PD problem

This is the section that matters most. Methylene blue is a potent inhibitor of monoamine oxidase A, the enzyme that breaks down serotonin, according to Ramsay, Dunford and Gillman (2007) [7]. That means it behaves like an MAOI drug. Taken alongside serotonergic medications (SSRIs, SNRIs, tricyclics, other MAOIs, certain migraine and pain drugs), it can drive serotonin to dangerous levels and trigger serotonin syndrome, which ranges from agitation and high fever to seizures and death. The FDA issued a formal drug safety communication about exactly this interaction [8].

The second hard stop is G6PD deficiency. In people who lack this enzyme, methylene blue can cause severe hemolysis, the rupture of red blood cells [1]. This is a genetic condition that is common in some populations and often undiagnosed, which is why medical guidance screens for it before use. MedlinePlus estimates that about 400 million people worldwide have G6PD deficiency, most often with roots in parts of Africa, Asia, the Mediterranean, and the Middle East [10]. Other reported effects include blue or green urine (harmless), nausea, headache, high blood pressure, and skin discoloration. At higher doses methylene blue can paradoxically cause the very methemoglobinemia it treats.

Put plainly: methylene blue is not a casual supplement. Anyone on an antidepressant, anyone with a family history of blood disorders, and anyone who is pregnant or breastfeeding should not use it without a clinician’s involvement.

Who prescribes methylene blue, and how do you find a clinic?

Hospital physicians prescribe methylene blue for its approved and established off-label uses. Outside the hospital, integrative and functional medicine physicians, naturopathic doctors where state law allows, and medical directors of IV clinics offer it, usually as oral drops or an IV drip, paid in cash. These are off-label uses, so insurance rarely covers them.

A careful clinic screens for G6PD deficiency, reviews every medication for serotonergic drugs, names the grade and source of the product, and explains plainly that the brain-fog evidence is early. The methylene blue treatment guide covers what a visit involves. To compare practices, the national list of clinics that offer IV therapy is a starting point, and NAD+ IV providers often offer methylene blue alongside NAD+.

Listing order on Regenerated.com is not paid ranking, Featured slots are labeled and capped, Verified means the clinic completed credential checks rather than paid for placement, and the directory is free for patients. The guide to Featured, Verified, and organic listings explains each label. Inclusion in the directory is not an endorsement of methylene blue or of any clinic.

Frequently asked questions

Is methylene blue FDA-approved?

Yes, but only for one thing. Methylene blue is FDA-approved as an intravenous treatment for methemoglobinemia, a blood disorder that blocks oxygen delivery to tissues. It is not approved or evaluated by the FDA as a cognitive enhancer, antidepressant, or anti-aging supplement. Those uses are off label or unregulated consumer applications, and the oral drops sold online for wellness are not FDA-approved drug products.

Can you take methylene blue with antidepressants?

No, not without direct medical supervision. Methylene blue is a strong MAO-A inhibitor, and combining it with SSRIs, SNRIs, tricyclics, or other serotonergic drugs can cause serotonin syndrome, a potentially fatal reaction with fever, agitation, and seizures. The FDA warned about this interaction specifically in a 2011 drug safety communication. Never mix the two on your own, and tell any prescriber about every medication and supplement you take.

What is the difference between pharmaceutical and aquarium grade methylene blue?

Purity. Pharmaceutical or USP grade is refined and tested to human standards, including limits for heavy metals. Aquarium and industrial grades are not, and can contain heavy metals like arsenic, lead, and mercury plus other contaminants. The two look identical in color, so only a lot-specific certificate of analysis from a verified pharmaceutical source, or product dispensed by a licensed pharmacy, confirms what you are taking.

Does methylene blue really help with brain fog?

The evidence is early and limited. One 2016 imaging study of 26 healthy adults showed a modest short-term memory and attention effect from a single oral dose of roughly 280 mg. There are no large or long-term trials showing it clears brain fog or improves cognition over time, and a 15-month Alzheimer's trial of a related compound was negative. Any benefit for brain fog remains unestablished.

Does aquarium methylene blue contain arsenic?

It can. Aquarium methylene blue is not made or tested for human use, so it is not held to the heavy metal limits that apply to pharmaceutical and USP grade product. Arsenic, lead, and mercury are the contaminants most often raised. Methylene blue itself contains no arsenic, so the risk comes from manufacturing and purification, which is why grade and a certificate of analysis matter.

Is methylene blue evidence-based?

Only for methemoglobinemia. That use is FDA-approved and backed by decades of hospital practice. For brain fog, memory, mood, and longevity, the human evidence is one small single-dose imaging study, animal work, and a negative phase 3 Alzheimer's trial of a related compound. The honest grade is Established for methemoglobinemia and Early to Insufficient for everything sold to consumers.

Bottom Line

Evidence grade: Established for methemoglobinemia, Early to Insufficient for everything the wellness market sells it for. Methylene blue is a real drug with a real mechanism and a genuine emergency-medicine role. It is not an established nootropic, antidepressant, or longevity compound. The human cognitive data is one small imaging study and a handful of niche experiments, nowhere near enough to justify daily self-dosing, and the largest brain trial of a related compound found no benefit.

Who it may suit: patients receiving it in a clinical setting for approved or credible off-label indications, under a doctor. Who should skip it: anyone on antidepressants or other serotonergic drugs, anyone with G6PD deficiency, pregnant or breastfeeding people, and anyone hoping a blue dye will fix fatigue or aging on its own. Honest limitation: the entire optimistic case rests on mechanism and animals, and mechanism has fooled us many times before. If you are drawn to it for energy or cognition, address the root cause first, use only pharmaceutical grade product free of arsenic and other heavy metal contamination, and treat methylene blue as experimental.

Related reading

• A grounded guide to anti-aging supplements
• Evidence-based supplements for brain fog
• Urolithin A and mitochondrial health
• Rapamycin for longevity: what the evidence shows
• NAD+ for brain fog: what the research supports

Sources

1. Methylene Blue. StatPearls, 2026. https://pubmed.ncbi.nlm.nih.gov/32491525/ ↩
2. Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue. Progress in Neurobiology, 2012. https://pubmed.ncbi.nlm.nih.gov/22067440/ ↩
3. Multimodal Randomized Functional MR Imaging of the Effects of Methylene Blue in the Human Brain. Radiology, 2016. https://pubmed.ncbi.nlm.nih.gov/27351678/ ↩
4. Preventing the return of fear using reconsolidation updating and methylene blue is differentially dependent on extinction learning. Scientific Reports, 2017. https://pubmed.ncbi.nlm.nih.gov/28397861/ ↩
5. Transmission-blocking activities of artesunate, chloroquine, and methylene blue on Plasmodium vivax gametocytes. Antimicrobial Agents and Chemotherapy, 2024. https://pubmed.ncbi.nlm.nih.gov/39058023/ ↩
6. Methylene blue mediated antimicrobial photodynamic therapy in clinical human studies: The state of the art. Photodiagnosis and Photodynamic Therapy, 2020. https://pubmed.ncbi.nlm.nih.gov/32473398/ ↩
7. Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction. British Journal of Pharmacology, 2007. https://pubmed.ncbi.nlm.nih.gov/17721552/ ↩
8. FDA Drug Safety Communication: Serious CNS reactions possible when methylene blue is given to patients taking certain psychiatric medications. U.S. Food and Drug Administration, 2011. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-serious-cns-reactions-possible-when-methylene-blue-given-patients ↩
9. Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial. The Lancet, 2016. https://pubmed.ncbi.nlm.nih.gov/27863809/ ↩
10. Glucose-6-phosphate dehydrogenase deficiency. MedlinePlus Genetics, U.S. National Library of Medicine. https://medlineplus.gov/genetics/condition/glucose-6-phosphate-dehydrogenase-deficiency/ ↩

Medical disclaimer: This article is for informational purposes only and is not medical advice. Methylene blue is a prescription drug with serious interactions and contraindications. Do not start, stop, or combine it with any medication or supplement without first consulting a qualified healthcare professional who knows your full history.